MedTrace Logo

ChordArt System for Mitral Regurgitation

NCT03581656 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2022-07-12

No results posted yet for this study

Summary

The ChordArt System is a novel catheter based technology for mitral chordal replacement that enables controlled implantation of artificial mitral chords to treat mitral regurgitation with a minimally invasive approach. The implant is designed to allow transfemoral antegrade implantation.

Conditions

  • Mitral Valve Repair
  • Mitral Regurgitation
  • Mitral Valve Insufficiency

Interventions

DEVICE

ChordArt System

The ChordArt System is intended for chordal replacement in mitral valve insufficiency due to leaflet prolapse or flail. One or more ChordArt System may be utilized within the same intervention for optimal mitral valve treatment.

Sponsors & Collaborators

  • Meditrial Europe Ltd.

    collaborator INDUSTRY

  • CoreMedic GmbH

    lead INDUSTRY

Principal Investigators

  • Kestutis Rucinskas, MD · Heart Surgery Centre, Santariskiu Vilnius

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-21
Primary Completion
2023-09-10
Completion
2023-12-31

Countries

  • Lithuania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581656 on ClinicalTrials.gov